DE60120370D1 - Hühner Leukämie-hemmender Faktor (LIF) und das dafür codierende Gen - Google Patents

Hühner Leukämie-hemmender Faktor (LIF) und das dafür codierende Gen

Info

Publication number
DE60120370D1
DE60120370D1 DE60120370T DE60120370T DE60120370D1 DE 60120370 D1 DE60120370 D1 DE 60120370D1 DE 60120370 T DE60120370 T DE 60120370T DE 60120370 T DE60120370 T DE 60120370T DE 60120370 D1 DE60120370 D1 DE 60120370D1
Authority
DE
Germany
Prior art keywords
lif
chickens
leukemia
gene coding
inhibiting factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60120370T
Other languages
English (en)
Other versions
DE60120370T2 (de
Inventor
Haruo Matsuda
Shuichi Furusawa
Hiroyuki Horiuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hiroshima University NUC
Original Assignee
Hiroshima University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hiroshima University NUC filed Critical Hiroshima University NUC
Application granted granted Critical
Publication of DE60120370D1 publication Critical patent/DE60120370D1/de
Publication of DE60120370T2 publication Critical patent/DE60120370T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/30—Bird
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60120370T 2001-06-07 2001-11-16 Hühner-Leukämie-hemmender Faktor (LIF) und das dafür codierende Gen Expired - Lifetime DE60120370T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001171993A JP3723839B2 (ja) 2001-06-07 2001-06-07 ニワトリの白血病阻止因子（ｌｉｆ）、及びそれをコードする遺伝子
JP2001171993 2001-06-07

Publications (2)

Publication Number Publication Date
DE60120370D1 true DE60120370D1 (de) 2006-07-20
DE60120370T2 DE60120370T2 (de) 2007-05-16

Family

ID=19013682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60120370T Expired - Lifetime DE60120370T2 (de) 2001-06-07 2001-11-16 Hühner-Leukämie-hemmender Faktor (LIF) und das dafür codierende Gen

Country Status (5)

Country Link
US (5) US7029664B2 (de)
EP (1) EP1264889B1 (de)
JP (1) JP3723839B2 (de)
AT (1) ATE329029T1 (de)
DE (1) DE60120370T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527966B2 (en) 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
US20040172667A1 (en) * 2002-06-26 2004-09-02 Cooper Richard K. Administration of transposon-based vectors to reproductive organs
WO2005062881A2 (en) * 2003-12-24 2005-07-14 Transgenrx, Inc. Gene therapy using transposon-based vectors
JP2008031043A (ja) * 2004-11-19 2008-02-14 Hiroshima Univ ニワトリｌｉｆタンパク質およびその利用
EP2143791B1 (de) 2007-03-28 2014-04-23 Hiroshima University Hühnerembryonale stammzelle und verfahren zur bewertung davon
WO2010036979A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of interferon
WO2010036976A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of antibodies
WO2010036978A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
WO2010118360A1 (en) * 2009-04-09 2010-10-14 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Production of proteins using transposon-based vectors
US10973658B2 (en) 2017-11-27 2021-04-13 Titan Spine, Inc. Rotating implant and associated instrumentation
CN108272855A (zh) * 2018-04-16 2018-07-13 贵州大学 一种抗禽白血病病毒中药

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2302747B1 (fr) * 1975-03-03 1978-09-22 Inst Nat Sante Rech Med Procede d'obtention, a partir de macrophages de mammiferes, d'un produit therapeutique actif, notamment, a l'egard des cellules tumorales humaines et produit therapeutique ainsi obtenu
JP2632317B2 (ja) * 1987-08-05 1997-07-23 有機合成薬品工業株式会社 ホップ矮化ウイロイド類の分別検出法
EP0453453B1 (de) * 1989-01-10 1996-09-11 Amrad Corporation Limited Leukämiehemmender faktor aus vieharten und seine verwendung zur verbesserung der implantation und der entwicklung von embryonalen zellen
JPH08154681A (ja) 1994-12-01 1996-06-18 Ito Ham Kk ウシｌｉｆ 遺伝子
JP2002511732A (ja) 1996-10-11 2002-04-16 ザ・テキサス・エイ・アンド・エム・ユニヴァーシティ・システム トランスジェニック動物を発生させるための組成物および方法
US5935813A (en) * 1997-03-20 1999-08-10 Incyte Pharmaceuticals, Inc. Human pancreatitis-associated protein
WO2000008132A1 (en) * 1998-08-03 2000-02-17 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Prolonged culturing of avian primordial germ cells using specific growth factors and use thereof

Also Published As

Publication number Publication date
US20050186626A1 (en) 2005-08-25
US20030056241A1 (en) 2003-03-20
DE60120370T2 (de) 2007-05-16
EP1264889A1 (de) 2002-12-11
US20080312426A1 (en) 2008-12-18
ATE329029T1 (de) 2006-06-15
US20080311654A1 (en) 2008-12-18
JP2003009869A (ja) 2003-01-14
US20090029458A1 (en) 2009-01-29
EP1264889B1 (de) 2006-06-07
JP3723839B2 (ja) 2005-12-07
US7771714B2 (en) 2010-08-10
US7029664B2 (en) 2006-04-18
US7250275B2 (en) 2007-07-31
US7691589B2 (en) 2010-04-06
US7619080B2 (en) 2009-11-17

Similar Documents

Publication Publication Date Title
DE60234193D1 (de) Stabilisierte faktor viii mit gentechnisch konstruierten disulfidbindungen
DE69916873D1 (de) Piezo tintenstrahltinten und verfahren zur herstellung und verwendung derselben
HK1112366A1 (en) Cultivated agarwood
DE69016315T2 (de) Harzbeschichteter verbindungsdraht, verfahren zur herstellung und halbleiteranordnung.
DE60234026D1 (de) Laminierter kern und verfahren zur herstellung des laminierten kerns
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE492167T1 (de) Verfahren zur herstellung von hundefutter
DE60120370D1 (de) Hühner Leukämie-hemmender Faktor (LIF) und das dafür codierende Gen
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
ATE453648T1 (de) Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
DE50310740D1 (de) Vorrichtung zur herstellung von anastomosen zwischen hohlorganen
ATE396180T1 (de) Verfahren zur herstellung von 2,6-diamino-4,5,6,7-tetrahydrobenzothiazol
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
ATE304062T1 (de) Vollnarbiges rindnappaleder und verfahren zur herstellung desselben
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE60213444D1 (de) Fluorpolymerlaminate und verfahren zur herstellung derselben
DE60333304D1 (de) Gleitteil und verfahren zur herstellung des gleitteils
DE60329470D1 (de) Vorrichtung zur herstellung von broschüren
DE60204334D1 (de) Verfahren zur herstellung von repaglinide
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
DE60218931D1 (de) Verfahren zur lauflängenbegrenzten Kodierung mit DSV Kontrolle
AT502793A5 (de) Grobkeramischer formkörper, verfahren zu dessen herstellung und verwendung
DE50205196D1 (de) Kabelführung und verfahren zur herstellung derselben
DE60033207D1 (de) Werkzeug zur herstellung von nockenwellen durch einwalzen
DE60236649D1 (de) Methode zur entfernung von allergenen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition